MA35134B1 - Derives de pyrazolidinz-3-one - Google Patents

Derives de pyrazolidinz-3-one

Info

Publication number
MA35134B1
MA35134B1 MA36463A MA36463A MA35134B1 MA 35134 B1 MA35134 B1 MA 35134B1 MA 36463 A MA36463 A MA 36463A MA 36463 A MA36463 A MA 36463A MA 35134 B1 MA35134 B1 MA 35134B1
Authority
MA
Morocco
Prior art keywords
derivatives
pyrazolidin
nitrogen
formula
relates
Prior art date
Application number
MA36463A
Other languages
English (en)
Inventor
Georg Jaeschke
Synese Jolidon
Lothar Lindemann
Antonio Ricci
Daniel Rueher
Heinz Stadler
Eric Vieira
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45998366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA35134(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA35134B1 publication Critical patent/MA35134B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention concerne des dérivés d'éthynyle de formule i dans laquelle x est n ou ch ; g est n ou ch ; à condition qu'au maximum un parmi x et g puisse être de l'azote ; r
MA36463A 2011-04-26 2013-11-22 Derives de pyrazolidinz-3-one MA35134B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11163708 2011-04-26
PCT/EP2012/057336 WO2012146552A1 (fr) 2011-04-26 2012-04-23 Dérivés de pyrazolidine-3-one

Publications (1)

Publication Number Publication Date
MA35134B1 true MA35134B1 (fr) 2014-05-02

Family

ID=45998366

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36463A MA35134B1 (fr) 2011-04-26 2013-11-22 Derives de pyrazolidinz-3-one

Country Status (24)

Country Link
US (1) US8648088B2 (fr)
EP (1) EP2702050B1 (fr)
JP (1) JP5753626B2 (fr)
KR (1) KR101576343B1 (fr)
CN (1) CN103492374B (fr)
AR (1) AR086037A1 (fr)
CA (1) CA2829171C (fr)
CL (1) CL2013003068A1 (fr)
CO (1) CO6801735A2 (fr)
CR (1) CR20130476A (fr)
EA (1) EA023146B1 (fr)
EC (1) ECSP13012990A (fr)
ES (1) ES2580333T3 (fr)
IL (1) IL229005A (fr)
MA (1) MA35134B1 (fr)
MX (1) MX2013011107A (fr)
MY (1) MY165141A (fr)
PE (1) PE20141168A1 (fr)
PH (1) PH12013501928A1 (fr)
SG (1) SG194095A1 (fr)
TW (1) TWI434840B (fr)
UA (1) UA113625C2 (fr)
WO (1) WO2012146552A1 (fr)
ZA (1) ZA201307404B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110862C2 (uk) * 2011-10-07 2016-02-25 Ф. Хоффманн-Ля Рош Аг Похідні етинілу як алостеричні модулятори метаботропного рецептора глутамату mglur 5
UA113223C2 (xx) * 2012-08-13 2016-12-26 Арилетинілпіримідини
UA116023C2 (uk) * 2013-07-08 2018-01-25 Ф. Хоффманн-Ля Рош Аг Етинільні похідні як антагоністи метаботропного глутаматного рецептора
AU2016273751B2 (en) * 2015-06-03 2020-04-02 F. Hoffmann-La Roche Ag Ethynyl derivatives
TR201909160T4 (tr) 2015-07-15 2019-07-22 Hoffmann La Roche Metabotropik glutamat reseptörü modülatörleri olarak etinil türevleri.
AR105556A1 (es) * 2015-08-03 2017-10-18 Hoffmann La Roche Derivados de etinilo
WO2018015235A1 (fr) 2016-07-18 2018-01-25 F. Hoffmann-La Roche Ag Dérivés d'éthynyle
WO2026072192A1 (fr) 2024-09-27 2026-04-02 Alto Neuroscience, Inc. Traitement efficace de la dépression chez des patients présentant des troubles cognitifs ou des difficultés d'apprentissage et/ou de mémoire avec un modulateur allostérique positif mglur5

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
AU2005336513B2 (en) * 2004-10-07 2012-08-09 Merck Sharp & Dohme Llc Thiazolyl mGluR5 antagonists and methods for their use
EP1809620B1 (fr) 2004-11-04 2010-12-29 Addex Pharma SA Nouveaux derives de tetrazole utilises comme modulateurs allosteriques positifs des recepteurs de glutamate metabotropiques
GB0510139D0 (en) 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds B1
KR20080034944A (ko) * 2005-08-19 2008-04-22 아스트라제네카 아베 결핵 치료용 피라졸론 유도체
KR20100033981A (ko) 2007-06-03 2010-03-31 벤더르빌트 유니버시티 벤즈아미드 대사성 글루타민산염 수용체5 양성 알로스테릭 조절자 및 이의 제조 및 사용방법
US8853392B2 (en) * 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same

Also Published As

Publication number Publication date
AU2012247654A1 (en) 2013-09-19
JP2014514315A (ja) 2014-06-19
EP2702050B1 (fr) 2016-05-18
ZA201307404B (en) 2014-06-25
CN103492374B (zh) 2016-06-01
KR101576343B1 (ko) 2015-12-09
JP5753626B2 (ja) 2015-07-22
PE20141168A1 (es) 2014-09-22
CL2013003068A1 (es) 2014-05-09
MY165141A (en) 2018-02-28
ECSP13012990A (es) 2013-11-29
US20120277243A1 (en) 2012-11-01
IL229005A0 (en) 2013-12-31
KR20130143141A (ko) 2013-12-30
PH12013501928A1 (en) 2013-11-25
NZ614883A (en) 2015-09-25
EA201391538A1 (ru) 2014-04-30
TW201309669A (zh) 2013-03-01
WO2012146552A1 (fr) 2012-11-01
US8648088B2 (en) 2014-02-11
ES2580333T3 (es) 2016-08-23
CN103492374A (zh) 2014-01-01
CA2829171C (fr) 2019-02-26
UA113625C2 (xx) 2017-02-27
TWI434840B (zh) 2014-04-21
MX2013011107A (es) 2013-10-17
EP2702050A1 (fr) 2014-03-05
IL229005A (en) 2016-02-29
CR20130476A (es) 2013-11-11
CO6801735A2 (es) 2013-11-29
CA2829171A1 (fr) 2012-11-01
HK1191329A1 (zh) 2014-07-25
SG194095A1 (en) 2013-11-29
AR086037A1 (es) 2013-11-13
EA023146B1 (ru) 2016-04-29

Similar Documents

Publication Publication Date Title
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
MA34006B1 (fr) Derives de dihydrofurane utilises comme composes insecticides
MA35402B1 (fr) Compositions pesticides et procédés associés
MA34831B1 (fr) Amides d'aminoindanes presentant une forte activite fongicide et leurs compositions phytosanitaires
MA39172B1 (fr) Dérivés bicycliques hétérocycliques comme inhibiteurs de bromodomaines
MA33275B1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine
MA35245B1 (fr) Pyridin-2-amides utiles comme agonistes de cb2
MA34078B1 (fr) Derives d'arylethynyle
MA35434B1 (fr) Amino-quinazolines en tant qu'inhibiteurs de kinase
MA39189A1 (fr) Dérivés de 1h-indazole et de 1h-indole antibactériens
MA35153B1 (fr) Immunoconjugués, compositions les contenant, et procédés de préparation et d'utilisation correspondants
CL2012000311A1 (es) Compuestos derivados que contiene ciclos con 3 atomos de nitrogeno; utiles en el tratamiento de parasitosis en animales.
EA201070988A1 (ru) Противовирусные терапевтические средства
MA37519A1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
MA38922A2 (fr) Dérivés de quinolizine substitués utiles en tant qu'inhibiteurs de l'integrase du vih
MA30695B1 (fr) Derives de n-(amino-heteroaryl)-1h-indole -2-carboxamides, leur preparation et leur application en therapeutique.
MA35364B1 (fr) Dérivés hétérocycliques bicycliques pour le traitement d'une hypertension artérielle pulmonaire
MA38583B1 (fr) Dérivés de dolastatine 10 et d'auristatines
MA37358B1 (fr) Composition de lutte antiparasitaire comprenant un nouveau dérivé d'iminopyridine
MA35086B1 (fr) Compose de triazolopyridine
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
MA38645A1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
MA38540A1 (fr) Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6
AR085037A1 (es) Acidos 6-amino-2-sustituido-5-vinilsililpirimidin-4-carboxilicos y esteres y acidos 4-amino-6-sustituido-3-vinilsililpiridin-picolinicos y esteres como herbicidas